BridgeMD
New treatment option for Chronic Pain
Official title Refining mUltiple Artificial intelliGence strateGies for Automatic Pain Assessment Investigations: RUGGI Study
ClinicalTrials.gov ID: NCT07038434
What this study is testing
- What it's testing
- This single-center, non-profit, observational-interventional study aims to develop artificial intelligence (AI) models for the automatic assessment of chronic pain (APA - Automatic Pain Assessment). The study will enroll adult patients with chronic pain of various origins (oncologic and non-oncologic).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults (≥18 years old) with chronic pain, defined according to IASP and ICD-11 as pain that persists or recurs for more than three months.
- Diagnosed with either:
- Chronic primary pain (e.g., fibromyalgia, irritable bowel syndrome, chronic headaches)
- Chronic secondary non-cancer pain (e.g., low back pain, osteoarthritis, post-surgical pain)
- Chronic cancer-related pain (due to cancer or its treatment)
You likely can't join if
- Current treatment with psychotropic drugs or presence of active psychiatric disorders (e.g., psychosis, major depression).
- Known history of alcohol or substance abuse.
- Pregnancy or breastfeeding.
- Age under 18 years.
- Inability to provide informed consent (e.g., due to cognitive impairment).
See the full eligibility criteria
- Adults (≥18 years old) with chronic pain, defined according to IASP and ICD-11 as pain that persists or recurs for more than three months.
- Diagnosed with either:
- Chronic primary pain (e.g., fibromyalgia, irritable bowel syndrome, chronic headaches)
- Chronic secondary non-cancer pain (e.g., low back pain, osteoarthritis, post-surgical pain)
- Chronic cancer-related pain (due to cancer or its treatment)
- Ability to understand the study procedures and provide written informed consent.
- Current treatment with psychotropic drugs or presence of active psychiatric disorders (e.g., psychosis, major depression).
- Known history of alcohol or substance abuse.
- Pregnancy or breastfeeding.
- Age under 18 years.
- Inability to provide informed consent (e.g., due to cognitive impairment).
The study team makes the final eligibility decision.
Where it's taking place
- Salerno, Italy, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Salerno, Italy, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.